A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control.

Cureus · 2023 · PMC9950847 · PMID 36846645

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Other items (FPG, AST, ALT, LDL-C, HDL-C, DBP) showed a decreasing trend in the dose-escalation group, although there was no significant difference.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.